CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-23 | Evans John M. CEO | Option exercise | +6,000 | $1.03 | $6K | 1,021,429 |
| 2021-04-23 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) | −6,000 | 396,345 | ||
| 2021-04-21 | Evans John M. CEO | Sale | −1,463 | $67.90 | $99K | 1,038,966 |
| 2021-04-21 | Evans John M. CEO | Sale | −5,079 | $69.02 | $351K | 1,033,887 |
| 2021-04-21 | Evans John M. CEO | Sale | −5,595 | $70.23 | $393K | 1,028,292 |
| 2021-04-21 | Evans John M. CEO | Sale | −9,869 | $71.38 | $704K | 1,018,423 |
| 2021-04-21 | Evans John M. CEO | Sale | −2,994 | $71.79 | $215K | 1,015,429 |
| 2021-03-31 | Evans John M. Chief Executive Officer | Other acquisition | +32 | 1,040,429 | ||
| 2021-03-31 | Burow Kristina Director | Other disposition | −200,000 | 3,521,520 | ||
| 2021-03-31 | Burow Kristina Director | Other disposition | −200,000 | 3,521,519 | ||
| 2021-03-31 | Burow Kristina Director | Other acquisition | +2,011 | 6,034 | ||
| 2021-03-31 | NELSEN ROBERT Director | Other disposition | −200,000 | 3,521,520 | ||
| 2021-03-31 | NELSEN ROBERT Director | Other disposition | −200,000 | 3,521,519 | ||
| 2021-03-31 | NELSEN ROBERT Director | Other acquisition | +4,686 | 14,053 | ||
| 2021-03-31 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −200,000 | 3,521,520 | ||
| 2021-03-31 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −200,000 | 3,521,519 | ||
| 2021-03-31 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +2,555 | 7,663 | ||
| 2021-03-31 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +811 | 2,434 | ||
| 2021-03-31 | Evans John M. CEO | Grant or award | +69,375 | 1,040,332 | ||
| 2021-03-31 | Evans John M. CEO | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 |
Page 26 of 32 · 630 trades